February 16, 2017 / 3:11 PM / 6 months ago

BRIEF-AMYGDALA NEUROSCIENCES ACQUIRES GS-6637 FROM GILEAD SCIENCES

Feb 16 (Reuters) - Amygdala Neurosciences:

* AMYGDALA NEUROSCIENCES ACQUIRES GS-6637 FROM GILEAD SCIENCES

* AMYGDALA NEUROSCIENCES SAYS "IN 2017, LOOK FORWARD TO INITIATING CLINICAL TRIALS FOR TREATMENT OF BOTH COCAINE AND ALCOHOL USE DISORDERS" FOR GS-6637 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below